CP Steuber

1.2k total citations
12 papers, 863 citations indexed

About

CP Steuber is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Oncology. According to data from OpenAlex, CP Steuber has authored 12 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 6 papers in Hematology and 4 papers in Oncology. Recurrent topics in CP Steuber's work include Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Lung Cancer Research Studies (4 papers). CP Steuber is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Lung Cancer Research Studies (4 papers). CP Steuber collaborates with scholars based in United States. CP Steuber's co-authors include JJ Shuster, VJ Land, DJ Pullen, MJ Borowitz, PG Dyment, Eva Hvizdala, MP Sullivan, WM Crist, Andrew J. Carroll and A. Thomas Look and has published in prestigious journals such as Blood and Leukemia.

In The Last Decade

CP Steuber

12 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
CP Steuber United States	10	688	588	257	159	150	12	863
G V Dahl United States	12	568 0.8×	620 1.1×	203 0.8×	212 1.3×	120 0.8×	15	890
TJ Vietti United States	12	673 1.0×	546 0.9×	184 0.7×	168 1.1×	155 1.0×	20	853
VJ Land United States	12	769 1.1×	664 1.1×	237 0.9×	173 1.1×	100 0.7×	15	916
WM Crist United States	12	788 1.1×	711 1.2×	207 0.8×	228 1.4×	141 0.9×	19	1.0k
JT Sandlund United States	9	580 0.8×	371 0.6×	297 1.2×	108 0.7×	88 0.6×	9	727
Marı́a Sara Felice Argentina	15	497 0.7×	401 0.7×	238 0.9×	140 0.9×	74 0.5×	46	736
E. Renate Panzer-Grümayer Austria	14	692 1.0×	614 1.0×	244 0.9×	203 1.3×	167 1.1×	20	1.0k
S Richards United Kingdom	14	498 0.7×	305 0.5×	316 1.2×	111 0.7×	257 1.7×	20	828
W.-D. Ludwig Germany	17	319 0.5×	449 0.8×	90 0.4×	204 1.3×	106 0.7×	37	754
Laura Burden United States	5	415 0.6×	377 0.6×	206 0.8×	78 0.5×	67 0.4×	7	605

Countries citing papers authored by CP Steuber

Since Specialization

Citations

This map shows the geographic impact of CP Steuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CP Steuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CP Steuber more than expected).

Fields of papers citing papers by CP Steuber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CP Steuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CP Steuber. The network helps show where CP Steuber may publish in the future.

Co-authorship network of co-authors of CP Steuber

This figure shows the co-authorship network connecting the top 25 collaborators of CP Steuber. A scholar is included among the top collaborators of CP Steuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CP Steuber. CP Steuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Lauer, S J, JJ Shuster, Naomi Winick, et al.. (2001). A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. Leukemia. 15(7). 1038–1045. 21 indexed citations

2.

Chang, M N, SC Raimondi, Yaddanapudi Ravindranath, et al.. (2000). Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia. 14(7). 1201–1207. 56 indexed citations

3.

Borowitz, MJ, SP Hunger, AJ Carroll, et al.. (1993). Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 82(4). 1086–1091. 1 indexed citations

4.

Borowitz, MJ, SP Hunger, AJ Carroll, et al.. (1993). Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 82(4). 1086–1091. 93 indexed citations

5.

Carroll, AJ, JJ Shuster, CP Steuber, et al.. (1993). Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602). Blood. 82(10). 3098–3102. 12 indexed citations

6.

Carroll, AJ, JJ Shuster, CP Steuber, et al.. (1993). Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602). Blood. 82(10). 3098–3102. 34 indexed citations

7.

Shuster, JJ, Andrew J. Carroll, A. Thomas Look, et al.. (1992). Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood. 79(12). 3316–3324. 137 indexed citations

8.

Shuster, JJ, Andrew J. Carroll, A. Thomas Look, et al.. (1992). Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood. 79(12). 3316–3324. 100 indexed citations

9.

Pui, CH, LS Frankel, AJ Carroll, et al.. (1991). Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases [see comments]. Blood. 77(3). 440–447. 221 indexed citations

10.

Pui, CH, LS Frankel, AJ Carroll, et al.. (1991). Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases [see comments]. Blood. 77(3). 440–447. 1 indexed citations

11.

Sullivan, MP, et al.. (1982). Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study. Blood. 60(4). 948–958. 108 indexed citations

12.

Sullivan, MP, et al.. (1982). Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study. Blood. 60(4). 948–958. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact